Amy Jacob

A recent study published in the British Journal of Dermatology reported a spike in the risk of depression among women afflicted with psoriasis.

The US Food and Drug Administration (FDA) today approved azelaic acid (Finacea Foam/Bayer) 15% for the treatment of inflammatory papules and pustules of mild-to-moderate rosacea.

Individuals afflicted with inflammatory bowel disease (IBD), like Crohn's disease (CD) or ulcerative colitis (UC), are twice as prone to developing generalized anxiety disorder compared to those without IBD.

For patients unable to have regular bowel movements the search for effective treatment can be uncomfortable with limited options. A potential new treatment is being tested where a vibrating capsule could help these patients with regular bodily functions.

The US Food and Drug Administration (FDA) recently granted approval for the ReShape Integrated Dual Balloon System (ReShape Dual Balloon) to treat obese adults without the need for invasive surgery.

The latest research has confirmed bariatric surgery or lifestyle modifications could significantly diminish levels of nonalcoholic steatohepatitis (NASH) in obese patients.

The US Food and Drug Administration recently approved sonidegib (Odomzo/Novartis) to treat patients suffering from locally advanced basal cell carcinoma – the most common form of advanced skin cancer – that had recurred post surgery or radiation therapy.

The US Food and Drug Administration (FDA) today approved daclatasvir (Daklinza/ Bristol-Myers Squibb) for use with sofosbuvir for the treatment of hepatitis C virus (HCV) genotype 3 infections.

Researchers have recently discovered that the sulfa-based compound ethoxzolamide found in many drugs for glaucoma treatment can be used successfully to treat tuberculosis (TB).

The US Food and Drug Administration today approved the Bio-Rad BioPlex 2200 HIV Ag-Ab assay, the first ever FDA-approved diagnostic capable of differentiating among HIV-1 antibodies, HIV-2 antibodies, and HIV-1 p24 antigens in human or plasma serums or specimens.

As telemedicine continues to receive favorable reviews from healthcare professionals and patients, SonarMD, LLC recently released its SonarMD platform for securely engaging, monitoring, and managing patients with chronic gastrointestinal diseases.

Scientists have, for the first time, transplanted lab-grown stem cells, successfully restoring a brutally damaged liver's organ function.

The new minimally invasive procedure, Cellfina System, was approved by the US Food and Drug Administration (FDA) to help clear the appearance of cellulite for at least a one-year period.

Patients afflicted with moderate-to- severe eczema have been successfully treated with rheumatoid arthritis drug, tofacitinib citrate.

Elective colectomy procedures significantly improve survival rates compared to existing medical therapy in ulcerative colitis (UC) patients aged 50 or older.

The US Food and Drug Administration (FDA) has approved once-daily, topical antibiotic-free adapalene and benzoyl peroxide (Epiduo Forte Gel/ Galderma Laboratories) for the treatment of acne vulgaris.

A new drug currently in testing, DSM265, may be exhibiting all the signs of a potential cure and preventative treatment for malaria – in a single dose.

Using nanotechnology to routinely release nitric oxide could potentially be an effective treatment method for acne.

Cirrhosis is a serious problem for patients with the condition and while treatment has made great strides in recent years there is still more that can be learned to help more patients with more effective treatments.

One of the biggest challenges in the fight against HIV and viral hepatitis has been the lack of knowledge some countries have about the spread of the diseases and ways to monitor the problem before it gets out of hand. The World Health Organization has been working to combat this issue in Europe and other parts of the world.

As hepatitis C becomes a more treatable disease the World Health Organization is increasing its efforts to treat people who are also infected with HIV as well as hepatitis C.

Researchers and Europe recently announced the results of a study looking at whether there is a connection between heavy alcohol consumption and the development of certain forms of cancer.

Researchers recently explored the mystery of what mechanisms cause alcohol liver disease, highlighting genetics -- particularly the molecule cytochrome P452.

A social problem with limited existing research, work has been done to understand the risks and benefits associated with administering non-selective beta blockers to elderly patients.

Anticoagulants may not be the ideal treatment for all patients with cirrhosis and portal hypertension but research is being done to find the best possible treatments for these patients.

Anacor Pharmaceuticals recently announced favorable results from two phase 3 pivotal studies for Crisaborole Topical Ointment, 2% (previously AN2728), a non-steroidal topical anti-inflammatory PDE-4 inhibitor for treating children and adults suffering from mild-to-moderate atopic dermatitis.

The Centers for Medicare and Medicaid Services (CMS) recently released the 2016 Medicare Fee Schedule (MPFS), which called for significant reductions in reimbursement rates for colonoscopies and other lower gastrointestinal (GI) procedures.

Successful preliminary trials revealed that treatment with a novel anti–interleukin-23 monoclonal antibody, guselkumab, (CNTO 1959/Janssen) was more effective at reducing the symptoms of plaque psoriasis than adalimumab.

As the summer grilling season swings into high gear, the Centers for Disease Control and Prevention (CDC) has issued a warning regarding the health risks from accidentally ingesting wire bristles from the brushes commonly used to clean BBQ grills.

As fecal microbiota transplantation (FMT) has gained acceptance and popularity as a treatment for c. difficile infection, researchers have also been investigating the benefits of the procedure for treating other disorders of the gut, including ulcerative colitis (UC).